Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pharmaniaga BhdXKLS:7081 45 Market Cap is RM1,547 Mil as of Jul. 18, 2026. GuruFocus rates XKLS:7081 with a GF Score™ of 45/100 and a GF Value™ of RM0.73 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 120 Medical Distribution companies, Pharmaniaga Bhd ranks better than 65% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Pharmaniaga Bhd's share price for the quarter that ended in Mar. 2026 was RM1.225. Pharmaniaga Bhd's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 1,311 Mil. Therefore, Pharmaniaga Bhd's market cap for the quarter that ended in Mar. 2026 was RM1,606 Mil.
Pharmaniaga Bhd's quarterly market cap
declined
from Sep. 2025 (RM1,902 Mil) to Dec. 2025 (RM1,869 Mil) and
declined
from Dec. 2025 (RM1,869 Mil) to Mar. 2026 (RM1,606 Mil).
Pharmaniaga Bhd's annual market cap
declined
from Dec. 2023 (RM555 Mil) to Dec. 2024 (RM512 Mil) but then
increased
from Dec. 2024 (RM512 Mil) to Dec. 2025 (RM1,869 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Pharmaniaga Bhd's Enterprise Value for Today is RM2,155 Mil.
Pharmaniaga Bhd (XKLS:7081) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Pharmaniaga Bhd Market Cap Related Terms
Pharmaniaga Bhd Market Cap Historical Data
* Premium members only.
The historical data trend for Pharmaniaga Bhd's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Pharmaniaga Bhd's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharmaniaga Bhd Market Cap vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Pharmaniaga Bhd's Market Cap distribution charts can be found below:
* The bar in red indicates where Pharmaniaga Bhd's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Pharmaniaga Bhd's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmaniaga Bhd (XKLS:7081) has a Market Cap of RM1,547 Mil as of Jul. 18, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Pharmaniaga Bhd and its competitors. According to the industry distribution chart, Pharmaniaga Bhd ranks #42 out of 120 companies in the Medical Distribution industry, placing it in the top 35%.
Is Pharmaniaga Bhd's Market Cap too high?
Pharmaniaga Bhd's current Market Cap is RM1,547 Mil. Based on the distribution chart, Pharmaniaga Bhd ranks #42 out of 120 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Pharmaniaga Bhd has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pharmaniaga Bhd's Market Cap compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Pharmaniaga Bhd ranks #42 out of 120 companies for Market Cap. This puts Pharmaniaga Bhd in the upper half of its industry. The industry median Market Cap is 146.35. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 146.35, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Pharmaniaga Bhd and its competitors. For the Medical Distribution industry, the median Market Cap is 146.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharmaniaga Bhd's current Market Cap is RM1,547 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmaniaga Bhd stock overvalued right now?
Based on GuruFocus' analysis, Pharmaniaga Bhd (XKLS:7081) is currently considered Significantly Overvalued. The stock's GF Value™ is RM0.73, compared to a current price of RM1.18 — trading 61.6% above its estimated fair value. The current Market Cap is RM1,547 Mil. Pharmaniaga Bhd's overall GF Score™ is 45/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Pharmaniaga Bhd (XKLS:7081), the current Market Cap is RM1,547 Mil as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pharmaniaga Bhd (XKLS:7081) Overvalued in 2026?
Based on GuruFocus' analysis, Pharmaniaga Bhd stock appears to be overvalued.
The current stock price of RM1.18 is trading 61.6% above its estimated GF Value™ of RM0.73.
GuruFocus considers Pharmaniaga Bhd to be Significantly Overvalued.
Key valuation signals for XKLS:7081:
Market Cap: RM1,547 Mil
GF Value™: RM0.73 vs. price of RM1.18 (61.6% above fair value)
No single metric tells the full story. See the XKLS:7081 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pharmaniaga Bhd is engaged in the manufacture of pharmaceuticals and medical devices. The company is also involved in logistics and distribution. The group operates in three segments - Logistics and distribution, Manufacturing in Malaysia, and Manufacturing and distribution in Indonesia. Maximum revenue is generated by the logistics and distribution segment in Malaysia. The Logistics and distribution segment is engaged in distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia.
45GF Score
Get the complete analysis for XKLS:7081
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7081 has been successfully added to your 
